FI973089A - Ihmisen interleukiini-1-reseptorin apuproteiini - Google Patents
Ihmisen interleukiini-1-reseptorin apuproteiini Download PDFInfo
- Publication number
- FI973089A FI973089A FI973089A FI973089A FI973089A FI 973089 A FI973089 A FI 973089A FI 973089 A FI973089 A FI 973089A FI 973089 A FI973089 A FI 973089A FI 973089 A FI973089 A FI 973089A
- Authority
- FI
- Finland
- Prior art keywords
- human interleukin
- auxiliary protein
- receptor
- receptor auxiliary
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37626895A | 1995-01-23 | 1995-01-23 | |
PCT/EP1996/000181 WO1996023067A1 (en) | 1995-01-23 | 1996-01-17 | Human interleukin-1 receptor accessory protein |
Publications (2)
Publication Number | Publication Date |
---|---|
FI973089A0 FI973089A0 (fi) | 1997-07-22 |
FI973089A true FI973089A (fi) | 1997-07-22 |
Family
ID=23484321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI973089A FI973089A (fi) | 1995-01-23 | 1997-07-22 | Ihmisen interleukiini-1-reseptorin apuproteiini |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0808365A1 (cs) |
JP (1) | JPH10512453A (cs) |
AR (1) | AR003919A1 (cs) |
AU (1) | AU4537096A (cs) |
BR (1) | BR9606837A (cs) |
CA (1) | CA2210724A1 (cs) |
CO (1) | CO4480033A1 (cs) |
CZ (1) | CZ208197A3 (cs) |
EA (1) | EA199700265A1 (cs) |
FI (1) | FI973089A (cs) |
HU (1) | HUP9702458A2 (cs) |
IL (1) | IL116796A0 (cs) |
MX (1) | MX9705501A (cs) |
NO (1) | NO973404L (cs) |
PE (1) | PE64396A1 (cs) |
PL (1) | PL321538A1 (cs) |
TR (1) | TR199700652T1 (cs) |
WO (1) | WO1996023067A1 (cs) |
ZA (1) | ZA96333B (cs) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998008969A1 (en) * | 1996-08-26 | 1998-03-05 | Human Genome Sciences, Inc. | Soluble interleukin-1 receptor accessory molecule |
US6974682B1 (en) | 1996-08-26 | 2005-12-13 | Human Genome Sciences, Inc. | Soluble interleukin-1 receptor accessory molecule |
ES2312179T3 (es) | 1996-12-06 | 2009-02-16 | Amgen Inc. | Terapia combinada que utiliza un inhibidor del il-1 para el tratamiento de enfermedades mediadas por el il-1. |
US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
EP0979282A1 (en) * | 1997-04-30 | 2000-02-16 | F. Hoffmann-La Roche Ag | Rat st38.2 chemokine |
US6280955B1 (en) * | 1997-12-16 | 2001-08-28 | Tularik Inc. | Interleukin-1 receptor accessory proteins, nucleic acids and methods |
EP1042477A1 (en) | 1997-12-23 | 2000-10-11 | Immunex Corporation | Sigirr dna and polypeptides |
US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
AU2002253842A1 (en) | 2000-10-31 | 2002-08-28 | Immunex Corporation | Il-1 receptor accessory protein |
GB2375604A (en) * | 2001-05-18 | 2002-11-20 | Warner Lambert Co | Methods for screening using interleukin soluble trimolecular complex |
SG10201603108QA (en) | 2001-06-26 | 2016-05-30 | Amgen Inc | Antibodies To OPGL |
KR100453877B1 (ko) | 2001-07-26 | 2004-10-20 | 메덱스젠 주식회사 | 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 TNFR/Fc 융합 단백질, 상기 단백질을 코딩하는 DNA, 상기 DNA를 포함하는벡터, 및 상기 벡터에 의한 형질전환체 |
MXPA04001187A (es) * | 2001-08-07 | 2004-07-08 | Immunex Corp | Receptores de interleucina-1 en el tratamiento de enfermedades. |
NZ538569A (en) | 2002-09-06 | 2009-02-28 | Amgen Inc | Therapeutic human anti-IL-1R1 monoclonal antibody |
US7619066B2 (en) | 2004-04-02 | 2009-11-17 | Amgen Inc. | IL-1ra variants |
WO2005105830A1 (en) * | 2004-05-05 | 2005-11-10 | Valorisation-Recherche, Societe En Commandite | Interleukin-1 receptor antagonists, compositions, and methods of treatment |
US8618054B2 (en) | 2004-05-05 | 2013-12-31 | Valorisation-Rechereche Société en Commandite | Interleukin-1 receptor antagonists, compositions, and methods of treatment |
EP1885855A4 (en) * | 2005-05-05 | 2009-03-04 | Valorisation Hsj Soc En Comman | CYTOKIN RECEPTOR MODULATORS AND USES THEREOF |
PE20070684A1 (es) | 2005-11-14 | 2007-08-06 | Amgen Inc | MOLECULAS QUIMERICAS DE ANTICUERPO RANKL-PTH/PTHrP |
EP2271673B1 (en) * | 2008-03-26 | 2016-02-24 | Cellerant Therapeutics, Inc. | Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof |
EP2196476A1 (en) | 2008-12-10 | 2010-06-16 | Novartis Ag | Antibody formulation |
US10017812B2 (en) | 2010-05-18 | 2018-07-10 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
GB2472856B (en) | 2009-08-21 | 2012-07-11 | Cantargia Ab | IL1-RAP modulators and uses thereof |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
CN107929730A (zh) * | 2011-01-19 | 2018-04-20 | 坎塔吉亚有限责任公司 | 抗il1rap抗体及其治疗人类的用途 |
WO2012177595A1 (en) * | 2011-06-21 | 2012-12-27 | Oncofactor Corporation | Compositions and methods for the therapy and diagnosis of cancer |
US8841418B2 (en) | 2011-07-01 | 2014-09-23 | Cellerant Therapeutics, Inc. | Antibodies that specifically bind to TIM3 |
GB201403875D0 (en) | 2014-03-05 | 2014-04-16 | Cantargia Ab | Novel antibodies and uses thereof |
GB201413913D0 (en) | 2014-08-06 | 2014-09-17 | Cantargia Ab | Novel antibodies and uses thereof |
EP3294906B1 (en) | 2015-05-11 | 2024-07-10 | Natera, Inc. | Methods for determining ploidy |
US10906971B2 (en) | 2015-06-26 | 2021-02-02 | Sanofi Biotechnology SAS | Monoclonal anti-IL-1RAcP antibodies |
EP3241845A1 (en) | 2016-05-06 | 2017-11-08 | MAB Discovery GmbH | Humanized anti-il-1r3 antibodies |
WO2018022982A1 (en) | 2016-07-29 | 2018-02-01 | Trustees Of Boston University | Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development |
EP3401332A1 (en) | 2017-05-08 | 2018-11-14 | MAB Discovery GmbH | Anti-il-1r3 antibodies for use in inflammatory conditions |
US11773434B2 (en) | 2017-06-20 | 2023-10-03 | The Medical College Of Wisconsin, Inc. | Assessing transplant complication risk with total cell-free DNA |
US12024738B2 (en) | 2018-04-14 | 2024-07-02 | Natera, Inc. | Methods for cancer detection and monitoring |
TW202021618A (zh) | 2018-08-17 | 2020-06-16 | 美商23與我有限公司 | 抗il1rap抗體及其使用方法 |
US11931674B2 (en) | 2019-04-04 | 2024-03-19 | Natera, Inc. | Materials and methods for processing blood samples |
WO2021236962A1 (en) | 2020-05-20 | 2021-11-25 | The Medical College Of Wisconsin, Inc. | Compositions and methods for inhibiting cytokine-release syndrome |
US20240224961A1 (en) * | 2021-05-28 | 2024-07-11 | Biocytogen Jiangsu Co., Ltd. | Genetically modified non-human animal with human or chimeric il1rap |
WO2024062074A1 (en) | 2022-09-21 | 2024-03-28 | Sanofi Biotechnology | Humanized anti-il-1r3 antibody and methods of use |
-
1996
- 1996-01-15 PE PE1996000031A patent/PE64396A1/es not_active Application Discontinuation
- 1996-01-16 ZA ZA96333A patent/ZA96333B/xx unknown
- 1996-01-17 EP EP96901291A patent/EP0808365A1/en not_active Withdrawn
- 1996-01-17 WO PCT/EP1996/000181 patent/WO1996023067A1/en not_active Application Discontinuation
- 1996-01-17 CA CA002210724A patent/CA2210724A1/en not_active Abandoned
- 1996-01-17 CZ CZ972081A patent/CZ208197A3/cs unknown
- 1996-01-17 PL PL96321538A patent/PL321538A1/xx unknown
- 1996-01-17 HU HU9702458A patent/HUP9702458A2/hu unknown
- 1996-01-17 MX MX9705501A patent/MX9705501A/es unknown
- 1996-01-17 BR BR9606837A patent/BR9606837A/pt unknown
- 1996-01-17 JP JP8522598A patent/JPH10512453A/ja active Pending
- 1996-01-17 EA EA199700265A patent/EA199700265A1/ru unknown
- 1996-01-17 TR TR97/00652T patent/TR199700652T1/xx unknown
- 1996-01-17 AU AU45370/96A patent/AU4537096A/en not_active Abandoned
- 1996-01-17 IL IL11679696A patent/IL116796A0/xx unknown
- 1996-01-19 AR ARP960101095A patent/AR003919A1/es unknown
- 1996-01-22 CO CO96002329A patent/CO4480033A1/es unknown
-
1997
- 1997-07-22 FI FI973089A patent/FI973089A/fi unknown
- 1997-07-23 NO NO973404A patent/NO973404L/no unknown
Also Published As
Publication number | Publication date |
---|---|
ZA96333B (en) | 1996-07-23 |
NO973404D0 (no) | 1997-07-23 |
CA2210724A1 (en) | 1996-08-01 |
FI973089A0 (fi) | 1997-07-22 |
JPH10512453A (ja) | 1998-12-02 |
BR9606837A (pt) | 1998-05-26 |
CZ208197A3 (en) | 1997-11-12 |
PL321538A1 (en) | 1997-12-08 |
AU4537096A (en) | 1996-08-14 |
HUP9702458A2 (hu) | 1998-04-28 |
IL116796A0 (en) | 1996-05-14 |
EA199700265A1 (ru) | 1998-04-30 |
NO973404L (no) | 1997-07-23 |
MX9705501A (es) | 1997-10-31 |
TR199700652T1 (xx) | 1998-02-21 |
WO1996023067A1 (en) | 1996-08-01 |
PE64396A1 (es) | 1997-01-28 |
AR003919A1 (es) | 1998-09-30 |
EP0808365A1 (en) | 1997-11-26 |
CO4480033A1 (es) | 1997-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI973089A (fi) | Ihmisen interleukiini-1-reseptorin apuproteiini | |
DE69634703D1 (de) | Mehrfach einstellbare Sitzeinheit | |
DE69634739D1 (de) | Höhenverstellbares armlehnengefüge | |
DE69612316D1 (de) | Gelenkige Armlehne | |
DK0779035T3 (da) | Modificeret valleprotein | |
BR9610239A (pt) | Proteínas de fusão-alérgeno-xcd32 | |
DE69517674D1 (de) | Verstellbare Sitzanordnung | |
FI955400A0 (fi) | Tuoli | |
DE69615850D1 (de) | G-protein-gekoppelter rezeptor hnfd578 | |
KR970007965U (ko) | 의자 | |
KR970019006U (ko) | 의자 | |
KR960030269U (ko) | 좌의자 | |
KR970007961U (ko) | 의자용 이색판 | |
FI103946B1 (fi) | Istuin | |
KR970008134U (ko) | 휠체어용 방석 | |
BR7502674U (pt) | Cadeira relax | |
SE9503962D0 (sv) | Ställbart ryggstöd | |
IT240237Y1 (it) | Sedia smontabile | |
KR970015433U (ko) | 쐐기형 인류 크램프 | |
KR970026773U (ko) | 의자 | |
KR970007957U (ko) | 의자 | |
KR960026611U (ko) | 등받이대 | |
KR970031423U (ko) | 릴렉스 시트 | |
KR960028635U (ko) | 시트용 진동기 | |
KR960036852U (ko) | 탈착이 용이한 아암레스트 |